MediFind
Condition

Adenosine Monophosphate Deaminase Deficiency

Symptoms, Doctors, Treatments, Research & More

Condition 101

What is the definition of Adenosine Monophosphate Deaminase Deficiency?

Adenosine monophosphate (AMP) deaminase deficiency is a condition that can affect the muscles used for movement (skeletal muscles). In many affected individuals, AMP deaminase deficiency does not cause any symptoms. People who do experience symptoms typically have fatigue, muscle pain (myalgia), or cramps after exercise or prolonged physical activity (exercise intolerance). Following strenuous activity, they often get tired more quickly and stay tired longer than would normally be expected. In rare cases, affected individuals have more severe symptoms including severe muscle weakness, low muscle tone (hypotonia), and muscle wasting (atrophy), but it is unclear whether these symptoms are due solely to AMP deaminase deficiency or additional health conditions. Exercise intolerance associated with AMP deaminase deficiency usually becomes apparent in childhood or early adulthood.

What are the causes for Adenosine Monophosphate Deaminase Deficiency?

AMP deaminase deficiency is caused by mutations in the AMPD1 gene, which provides instructions for producing an enzyme called AMP deaminase. This enzyme is found in skeletal muscles, where it plays a role in producing energy. Skeletal muscle cells need energy to function and move the body.

Mutations in the AMPD1 gene often result in an AMP deaminase enzyme that cannot function and as a result, energy production in skeletal muscle cells is decreased. Skeletal muscles are particularly sensitive to decreases in energy during periods of exercise or increased activity when energy demands increase. The lack of AMP deaminase activity can result in fatigue, muscle weakness or pain, or other muscle problems in some people with AMP deaminase deficiency.

It is not known why some people with this condition do not experience symptoms. Researchers speculate that additional factors, both genetic and environmental, may determine whether a person develops the signs and symptoms of AMP deaminase deficiency.

How prevalent is Adenosine Monophosphate Deaminase Deficiency?

AMP deaminase deficiency is one of the most common inherited muscle disorders in white populations, affecting 1 in 50 to 100 people. The prevalence is lower in African Americans, affecting an estimated 1 in 40,000 people, and the condition is even less common in the Japanese population.

Is Adenosine Monophosphate Deaminase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Top Global Doctors

Latest Research

Latest Advance
Study
  • Condition: Pediatric acute lymphoblastic leukemia (ALL)
  • Journal: Pediatric blood & cancer
  • Treatment Used: Metformin with induction chemotherapy.
  • Number of Patients: 14
  • Published —
The phase 1 study assessed the safety and efficacy of metformin ( a medication that has been known to cause acute lymphoblastic leukemia cells in vitro) in combination with relapse induction therapy for patients with acute lymphoblastic leukemia (ALL).

Clinical Trials

There are no recent clinical trials available for this condition. Please check back because new trials are being conducted frequently.